Impact of variation in biliopancreatic bowel limb length between 200-cm and 250-cm on weight loss following one site stomach to jejunum joining in patients with obesity

The Effect of 200-cm versus 250-cm Biliopancreatic Limb in Single Anastomosis Sleeve jejunal Bypass on weight loss following Bariatric Surgery: A PHASE II Randomized Controlled Trial - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084396

Enrollment

Registered

2025-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Group A: SAS-J 200cm BPLL: Single Anastomosis Sleeve Jejunal Bypass

that is a segment of proximal jejunum is anastomosed to the pre-pyloric part of sleeve gastrectomy. About 5cm size anastomosis will be created, and about 200-cm segment of jejunum distal to DJ-flexure

that is a segment of proximal jejunum is anastomosed to the pre-pyloric part of sleeve gastrectomy. About 5cm size anastomosis will be created, and about 250-cm segment of jejunum distal to DJ-flexure

Eligibility

Inclusion criteria

Inclusion criteria: 1. BMI more than 27.5 with Diabetes Mellitus 2. BMI more than 32.5 3. Asian population

Exclusion criteria

Exclusion criteria: 1. Refusal to participate in the study 2. Biopsy proven Chronic liver disease 3. Protein loosing enteropathy 4. Revision bariatric surgery 5. Pregnancy, lactating mother 6. Failure to comply with the post-operative protocol (dietary advises and exercise etc.) 7. Pituitary tumors or adrenal tumors 8. Long term use of anti-depressants or immunosuppressant s including corticosteroids

Design outcomes

Primary

Measure	Time frame
Efficacy of SASJ between the two groupsTimepoint: 6 and 12 months	—

Secondary

Measure	Time frame
1.Remission of comorbidities: Diabetes mellitus (HBA1C), Hypertension, Dyslipidemia, Hypothyroidism, OSA, and Non Alcoholic Fatty liver, Gastro-esophageal reflux disease, and Albuminuria 2.Complications: Bleeding, Anastomotic leak, GERD, Vomiting, Marginal ulcer, DVT, and SSI Timepoint: 1. 6 months and 1 year 2. up to post-operative day 30	—

Countries

India

Contacts

Public ContactDr Angshuman Dutta

All India Institute of Medical Sciences New Delhi

angshumandutta8820@gmail.com8486252608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026